Trintellix vs Lexapro: What the Evidence Says About Brain Fog

Your mood has lifted. You’re sleeping again, and the heaviness is mostly gone. But you still read the same email three times, lose words mid-sentence, and feel a half step behind in meetings. If that sounds familiar, you’ve probably wondered whether a different antidepressant would help you think clearly again, and Trintellix often comes up.

Your ability to focus depends on some of the same brain systems that depression disrupts. Attention, memory, and the speed at which you process information all draw on networks that serotonin helps regulate, which is why cognitive symptoms travel with low mood so often. Comparing two medications for those symptoms takes precision about what each one was actually tested on.

Lexapro, the brand name for escitalopram, is one of the most widely used starting points for depression. The Lexapro prescribing information approves it for major depression in adults and teens 12 and older and for generalized anxiety disorder in adults and children 7 and older. A 522-trial network meta-analysis found escitalopram, along with vortioxetine, among the antidepressants that were more effective and better tolerated in head-to-head trials. The results are real, and the evidence is well established.

But feeling less depressed doesn’t always mean thinking clearly again, and at Siggy we think brain fog deserves its own answer rather than an assumption that it will clear with mood. Trintellix (vortioxetine) blocks serotonin reuptake and also acts on several serotonin receptors, and its FDA label includes trial data on processing speed, an aspect of thinking that depression can slow. The research suggests a measurable but modest cognitive edge in some comparisons, and it doesn’t settle the question in others. The real difference between these two drugs comes down to which symptoms you need treated most.

What This Page Covers

• The Short Answer
• How Trintellix and Lexapro Work Differently
• Why Cognitive Symptoms Matter in Depression
• What the Cognitive Trials Actually Show
• Trintellix vs Lexapro at a Glance
• Side Effects and Sexual Function
• When a Prescriber May Consider Trintellix

The Short Answer

Both medications treat depression well, and neither is the right first choice for everyone. Lexapro has a longer track record, an anxiety approval, and fewer drug interaction concerns. Trintellix has the stronger evidence on cognitive symptoms and may be easier on sexual function, though its cognitive advantage is small and some studies haven’t found it.

In practice, prescribers tend to reach for Trintellix when brain fog, slowed thinking, or SSRI sexual side effects are the problems getting in the way, and for Lexapro when anxiety is prominent or a well-studied first step makes the most sense.

How Trintellix and Lexapro Work Differently

Lexapro is a selective serotonin reuptake inhibitor, or SSRI. It blocks the transporter that recycles serotonin, so more serotonin stays active between nerve cells. An escitalopram pharmacokinetic review describes it as unlikely to cause clinically significant drug interactions, with a half-life of about 27 to 33 hours.

Trintellix does that too, and more. The Trintellix prescribing information describes it as a serotonin reuptake inhibitor that is also an agonist at 5-HT1A receptors, a partial agonist at 5-HT1B receptors, and an antagonist at 5-HT3, 5-HT1D, and 5-HT7 receptors. The label is candid that the contribution of these receptor effects to its antidepressant action hasn’t been established.

The practical differences show up elsewhere. Trintellix is approved only for major depression in adults. Its label calls for halving the dose alongside strong CYP2D6 inhibitors such as bupropion, fluoxetine, or paroxetine. It also has a long half-life of about 66 hours, more than twice that of escitalopram.

Why Cognitive Symptoms Matter in Depression

Trouble concentrating is one of the core symptoms of depression, and it tends to linger. In a three-year cohort study of 267 primary care patients, cognitive problems were one of three symptoms, along with low energy and sleep problems, that were present 85% to 94% of the time during depressive episodes and 39% to 44% of the time during remission.

That second number is the one that matters for this comparison. Many people who respond to an antidepressant still feel foggy at work or school, and the study’s authors describe residual symptoms as a substantial risk factor for relapse. Feeling better and feeling like yourself again can be two different places, and it’s worth telling your prescriber which one describes you.

What the Cognitive Trials Actually Show

The strongest data come from two 8-week trials the FDA reviewed. In the FOCUS cognition trial of 602 adults with recurrent depression, both 10 mg and 20 mg of vortioxetine improved a composite score of processing speed, learning, and memory more than placebo. The CONNECT cognition trial enrolled adults who reported cognitive problems and found vortioxetine improved scores on the Digit Symbol Substitution Test, a timed symbol-matching task, while duloxetine did not separate from placebo on that test.

The FDA added these results to the Trintellix label, with two important caveats. The label states that the effect on the symbol test may reflect improvement in depression, and that no comparative studies were done to show an advantage over other antidepressants on that test. Both trials were funded by the manufacturer.

Broader evidence points the same way. A 2025 network meta-analysis of 40 randomized trials found vortioxetine was the only antidepressant with a small, significant cognitive benefit over placebo, while escitalopram, citalopram, paroxetine, and fluoxetine didn’t differ from placebo. A 2018 network analysis by authors including manufacturer employees found vortioxetine outperformed escitalopram on the symbol test.

The direct comparison is less decisive. In a 2024 randomized trial in China of 131 patients followed for 8 weeks, both vortioxetine and escitalopram improved mood and cognitive scores, with no significant difference between them. In older adults, a VESPA trial analysis found vortioxetine wasn’t superior to SSRIs for depression outcomes over 6 months.

Taken together, Trintellix has the most consistent cognitive signal among the antidepressants studied, the effect is small, and escitalopram may help cognition too as depression lifts. Our overview of Trintellix for depression covers the broader efficacy picture.

Trintellix vs Lexapro at a Glance

The table below summarizes key differences drawn from the Trintellix and Lexapro prescribing information and the escitalopram pharmacokinetic review cited above.

Feature	Trintellix	Lexapro
FDA-approved uses	Depression in adults	Depression (age 12+), GAD (age 7+)
How it works	Reuptake plus receptor effects	Selective reuptake blocking
Usual dosing	10 mg, then 20 mg as tolerated	10 mg, up to 20 mg
Half-life	About 66 hours	About 27 to 33 hours
Nausea in trials	21% to 32% vs 9% placebo	15% vs 7% placebo
Processing speed data on label	Yes, vs placebo	No

For a wider look at how escitalopram compares with other SSRIs, see our guide to SSRI medications compared.

Side Effects and Sexual Function

Nausea is the tradeoff that comes with Trintellix. In its label, nausea rose with dose, was usually mild to moderate, and lasted a median of about two weeks. Our Trintellix dosage guide walks through how nausea changes at each step.

Sexual side effects are where many people feel the difference. The Lexapro label reports ejaculation problems in 12% of men versus 1% on placebo and decreased libido in 6% versus 2%, and it warns that label figures likely underestimate real-world rates. When Trintellix trials measured sexual function with a questionnaire in people without problems at baseline, new sexual dysfunction occurred in 16% to 29% of men and 22% to 34% of women, compared with 14% and 20% on placebo. The two labels used different methods, so the numbers can’t be compared directly.

A switch study offers a cleaner answer. In a head-to-head switch trial, adults whose depression was well treated but who had sexual side effects on citalopram, paroxetine, or sertraline were switched to vortioxetine or escitalopram for 8 weeks. Sexual function improved in both groups, more so with vortioxetine, and both kept their antidepressant response. The trial was funded by the manufacturer.

When a Prescriber May Consider Trintellix

The CANMAT 2023 guidelines note that vortioxetine, bupropion, and SNRIs may work better than SSRIs for cognitive symptoms, and they list vortioxetine among antidepressants with lower rates of sexual side effects. That lines up with the situations where Trintellix tends to come up:

• Thinking, focus, or memory problems are the most disruptive part of your depression.
• An SSRI helped your mood but caused sexual side effects you couldn’t live with.
• A first antidepressant didn’t work well enough and a switch is on the table.

Lexapro often stays the better fit when anxiety is a major part of the picture, when you’re under 18, or when a medication that strongly inhibits CYP2D6 would complicate Trintellix dosing. None of these are hard rules. They’re starting points for a conversation, and the right answer depends on your history, other medications, and what matters most to you.

If you’re already on Lexapro, don’t stop it on your own to try something new. Any change should be planned with your prescriber, because stopping an antidepressant suddenly can cause withdrawal symptoms and a return of depression.

Brain fog is easy to lose when you retell your story, because it’s hard to describe and easy to overlook when mood looks better on paper.

Trintellix and Lexapro are both solid choices with different strengths. Lexapro offers a long track record and anxiety coverage. Trintellix offers the most consistent, if modest, evidence for cognitive symptoms and a possible advantage for sexual function. If your mood has improved but your thinking hasn’t, that’s worth naming specifically, because it can change which option makes the most sense.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication. If you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.